Back to News
Market Impact: 0.1
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc.
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Pomerantz LLP said it is investigating claims on behalf of investors in Foghorn Therapeutics Inc. The announcement provided no details about the claims, alleged conduct, or potential financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
FHTX-0.50
More News
- Evercore ISI cuts Foghorn Therapeutics stock rating on trial failure
- US fines Bank of America $1.2bn for money laundering, sanctions violations
- Bank of America hit with more than $1.2 billion in penalties over money-laundering violations
- FBI arrests OpenAI employee accused of planting secret recording device in conference room
- Why is Bank of America stock sliding today?
- How tech icon Meg Whitman is already leaving her mark on grocery giant Albertsons